TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
ErGe BioTech AB
Closing information (x1000 NOK)
| Closing information | 2023/04 | 2022/04 | 2021/04 |
| Turnover |
1,479
|
1,247
|
1,324 |
| Financial expenses |
1
|
1
|
0 |
| Earnings before taxes |
525
|
435
|
465 |
| EBITDA |
526
|
436
|
465 |
| Total assets |
1,899
|
1,426
|
1,190 |
| Current assets |
835
|
446
|
332 |
| Current liabilities |
172
|
218
|
284 |
| Equity capital |
1,598
|
1,093
|
867 |
| - share capital |
52
|
48
|
49 |
| Employees (average) |
1
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Solvency |
84.1%
|
76.6%
|
72.9% |
| Turnover per employee |
1,479
|
624
|
662 |
| Profit as a percentage of turnover |
35.5%
|
34.9%
|
35.1% |
| Return on assets (ROA) |
27.7%
|
30.6%
|
39.1% |
| Current ratio |
485.5%
|
204.6%
|
116.9% |
| Return on equity (ROE) |
32.9%
|
39.8%
|
53.6% |
| Change turnover |
123
|
-42
|
42 |
| Change turnover % |
9%
|
-3%
|
3% |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-50%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.